Frontlight ResearchEarly access
Pancreatic cancer trials in United Kingdom
56 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2WithdrawnAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Glasgow, Leeds, London, Oxford
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - No phaseTaking peopleSurveillance of Pancreatic Health After Diabetes Diagnosis
- Where
- Ashton-under-Lyne, Birmingham, Bournemouth, Brockham, Bromborough, Burton-on-Trent, Epsom, Kibworth Beauchamp, Kingswinford, Leek, Leicester, London, Maidstone, Manchester, Nottingham, Portsmouth, Rossendale, Ruislip, Sandbach, Southampton, Stratford-upon-Avon, Uttoxeter, Uxbridge, Walsall, Warlingham, Weymouth
- Age
- 50 years to 84 years
- People
- 5,000
- Run by
- University Hospital Southampton NHS Foundation Trust
See details and how to joinNCT06803771 - Phase 1/2Taking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Dundee, London, Metropolitan Borough of Wirral, Oxford
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Edinburgh, London
- Age
- 18 years to 99 years
- People
- 24,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - Phase 1/2Taking peopleStudy to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- Where
- Glasgow, London, Manchester, Newcastle upon Tyne, Oxford
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT05985655 - Phase 1/2Taking peopleTT-702 in Patients With Advanced Solid Tumours.
- Where
- London, Manchester, Southampton
- Age
- 16 years and over
- People
- 60
- Run by
- Cancer Research UK
See details and how to joinNCT05272709 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- London, Sutton
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 1Taking peopleStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Where
- London, Manchester, Newcastle upon Tyne
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- MOMA Therapeutics
See details and how to joinNCT06545942 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- London, Sutton
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Edinburgh, London
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - No phaseTaking peopleExercise to Improve Outcomes in Pancreatic Cancer
- Where
- Guildford
- Age
- 18 years and over
- People
- 60
- Run by
- University of Surrey
See details and how to joinNCT07710495 - No phaseTaking peopleVolatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
- Where
- London
- Age
- 18 years and over
- People
- 6,079
- Run by
- Imperial College London
See details and how to joinNCT07243262 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Birmingham, London, Sutton
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - No phaseTaking peopleTumour Regulatory Molecules in Early Pancreatic Cancer Detection
- Where
- Cottingham
- Age
- 18 years and over
- People
- 180
- Run by
- Hull University Teaching Hospitals NHS Trust
See details and how to joinNCT03536793 - No phaseTaking peopleVolatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
- Where
- London
- Age
- 18 years and over
- People
- 1,005
- Run by
- Imperial College London
See details and how to joinNCT05727020 - Phase 1/2Taking peopleA Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
- Where
- London, Manchester, Newcastle upon Tyne, Southampton
- Age
- 18 years and over
- People
- 167
- Run by
- Cancer Research UK
See details and how to joinNCT06380816 - No phaseNot yet taking people in United KingdomMRinRT: Swansea University and SWWCC Collaboration Study.
- Where
- Swansea
- Age
- 18 years and over
- People
- 165
- Run by
- Swansea Bay University Health Board
See details and how to joinNCT07365124 - No phaseTaking peopleIn-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
- Where
- Nottingham
- Age
- 16 years and over
- People
- 160
- Run by
- University of Nottingham
See details and how to joinNCT07206355 - No phaseTaking peopleCancer Loyalty Card Study 2 (CLOCS-2)
- Where
- London
- Age
- 18 years and over
- People
- 2,900
- Run by
- Imperial College London
See details and how to joinNCT06447064 - No phaseTaking peopleFeasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
- Where
- Exeter
- Age
- 18 years to 99 years
- People
- 450
- Run by
- Origin Sciences
See details and how to joinNCT05102110 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- London, Manchester
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 1/2Taking peoplePhase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
- Where
- Headington
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- Auricula Biosciences Inc.
See details and how to joinNCT07148128 - No phaseTaking peopleThe CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
- Where
- Cambridge, London
- Age
- 40 years to 75 years
- People
- 6,000 worldwide
- Run by
- Javier Toledo
See details and how to joinNCT06717295 - No phaseTaking peopleREVOLUTION Surgery (REVOLUTION Surgery)
- Where
- Edinburgh
- Age
- 18 years and over
- People
- 200
- Run by
- University of Edinburgh
See details and how to joinNCT05642819 - Phase 2/3Taking peopleDETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- Age
- 12 years and over
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT05786716